{"id":"https://openalex.org/W3136589757","doi":null,"title":"Possible Diabetogenic Effects of Statins Therapy and its Clinical Implications","display_name":"Possible Diabetogenic Effects of Statins Therapy and its Clinical Implications","alternate_titles":[],"publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W3136589757","mag":"3136589757"},"language":"en","primary_location":{"id":"mag:3136589757","doi":null,"is_oa":true,"landing_page_url":"https://www.longdom.org/open-access/possible-diabetogenic-effects-of-statins-therapy-and-its-clinical-implications.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764833320","display_name":"Clinical and Experimental Pharmacology","issn_l":"2161-1459","issn":["2161-1459"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Clinical and Experimental Pharmacology","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W3136589757"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.longdom.org/open-access/possible-diabetogenic-effects-of-statins-therapy-and-its-clinical-implications.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081864978","display_name":"Agumas Alemu Alehegn","orcid":"https://orcid.org/0000-0001-5396-1735","observed_orcids":["https://orcid.org/0000-0001-5396-1735"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Agumas Alemu Alehegn","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5396-1735","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041309383","display_name":"ZemeneDemelashKifle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ZemeneDemelashKifle","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5002864306","display_name":"Mohammedbrhan Abdelwuh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohammedbrhan Abdelwuh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1609,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.41482336,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":92},"biblio":{"volume":"11","issue":"1","first_page":"1","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.010400000028312206,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9990000128746033},{"id":"https://openalex.org/keywords/diabetogenic-effect","display_name":"diabetogenic effect","score":0.7929999828338623},{"id":"https://openalex.org/keywords/new-onset-diabetes","display_name":"new-onset diabetes","score":0.9900000095367432},{"id":"https://openalex.org/keywords/hmg-coa-reductase-inhibition","display_name":"HMG-CoA reductase inhibition","score":0.9580000042915344},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.8820000290870667},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.6700000166893005},{"id":"https://openalex.org/keywords/adiponectin","display_name":"adiponectin","score":0.8899999856948853},{"id":"https://openalex.org/keywords/coenzyme-q10","display_name":"coenzyme Q10","score":0.9470000267028809},{"id":"https://openalex.org/keywords/lipoprotein-size","display_name":"lipoprotein particle size","score":0.890999972820282},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.8289999961853027},{"id":"https://openalex.org/keywords/inflammasome","display_name":"inflammasome","score":0.8820000290870667},{"id":"https://openalex.org/keywords/hyperlipidemia","display_name":"hyperlipidemia","score":0.8330000042915344},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.8999999761581421},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.4359999895095825}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8435614109039307},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.7010475397109985},{"id":"https://openalex.org/C2776782570","wikidata":"https://www.wikidata.org/wiki/Q357439","display_name":"Adiponectin","level":4,"score":0.6099932193756104},{"id":"https://openalex.org/C2779091943","wikidata":"https://www.wikidata.org/wiki/Q1079120","display_name":"Hyperlipidemia","level":3,"score":0.603569507598877},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.5392931699752808},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4878137409687042},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4658316969871521},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.43992969393730164},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4219409227371216},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.4105755686759949},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3136589757","doi":null,"is_oa":true,"landing_page_url":"https://www.longdom.org/open-access/possible-diabetogenic-effects-of-statins-therapy-and-its-clinical-implications.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764833320","display_name":"Clinical and Experimental Pharmacology","issn_l":"2161-1459","issn":["2161-1459"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Clinical and Experimental Pharmacology","raw_type":null}],"best_oa_location":{"id":"mag:3136589757","doi":null,"is_oa":true,"landing_page_url":"https://www.longdom.org/open-access/possible-diabetogenic-effects-of-statins-therapy-and-its-clinical-implications.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764833320","display_name":"Clinical and Experimental Pharmacology","issn_l":"2161-1459","issn":["2161-1459"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Clinical and Experimental Pharmacology","raw_type":null},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2586458334","https://openalex.org/W2219679120","https://openalex.org/W1883824268","https://openalex.org/W3030901613","https://openalex.org/W2113089156","https://openalex.org/W3087371559","https://openalex.org/W2460306507","https://openalex.org/W2522268504","https://openalex.org/W2942901292","https://openalex.org/W4387058649"],"abstract_inverted_index":{"Statins,":[0],"hydroxyl-methyl-glutaryl-coenzyme-A":[1],"reductive":[2],"inhibitors,":[3],"are":[4,69],"efficacious":[5],"and":[6,15,18,35,54,66,106],"safe":[7],"drugs":[8,145],"used":[9],"for":[10],"the":[11,28,52,75,132],"management":[12],"of":[13,30,41,56,78,87,98,134,144,168],"hyperlipidemia":[14],"preventing":[16],"primary":[17],"secondary":[19],"cardiovascular":[20,154],"disorders.":[21],"This":[22],"reduction":[23,29],"is":[24,82,160,173],"directly":[25],"proportional":[26],"to":[27,72,138,157],"LDL-cholesterol.":[31],"However,":[32,165],"different":[33],"population-based":[34],"Meta-analyses":[36],"studies":[37],"showed":[38],"an":[39],"incidence":[40],"new-onset":[42,79],"diabetes":[43,80],"mellitus":[44,81],"(NODM).":[45],"Older":[46],"age,":[47],"females,":[48],"obesity,":[49],"Asian":[50],"descent,":[51],"potency":[53],"intensity":[55],"statin":[57],"therapy,":[58],"existing":[59,139],"metabolic":[60],"disorders,":[61],"altered":[62],"blood":[63],"glucose":[64],"levels,":[65],"increased":[67],"weight":[68],"highly":[70],"prone":[71],"diabetes.":[73],"Although,":[74],"definitive":[76],"cause":[77],"not":[83,147],"ruled":[84],"out,":[85],"plenty":[86],"mechanisms":[88,110],"have":[89,128],"been":[90],"suggested":[91],"including":[92],"inhibiting":[93],"HMG-CoA":[94],"reductase,":[95],"decreasing":[96,104,118],"expression":[97],"GLUTs,":[99],"modifying":[100],"lipoprotein":[101],"particle":[102],"size,":[103],"adiponectin":[105],"ubiquinone":[107],"levels.":[108],"These":[109],"result":[111],"in":[112,150],"either":[113],"increasing":[114],"insulin":[115,119],"resistance":[116],"or":[117],"secretion.":[120],"In":[121],"addition,":[122],"under":[123],"dysmetabolic":[124],"situations,":[125],"statins":[126],"may":[127],"pro-inflammatory":[129],"effects":[130],"through":[131],"induction":[133],"certain":[135],"inflammasomes.":[136],"According":[137],"evidence,":[140],"prescribing":[141],"this":[142],"class":[143],"should":[146],"be":[148],"restricted":[149],"patients":[151],"with":[152],"high":[153],"risk":[155,159],"due":[156],"their":[158,163],"lower":[161],"than":[162],"benefits.":[164],"close":[166],"monitoring":[167],"commonly":[169],"available":[170],"lab":[171],"tests":[172],"recommended.":[174]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3136589757","counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2021-03-29T00:00:00"}
